July 14, 2010

Avandia restrictions or removal from market recommended by federal advisory panel

On Wednesday, July 14, 2010, a divided federal advisory committee recommended to the FDA that Avandia either be removed from the market, or strict new warnings be imposed on the drug because it may increase risks associated with heart attacks. Contributing to the recommendation was skepticism by panel members involving the integrity of studies sponsored by GlaxoSmithKline and documentation showing that the manufacturer withheld important safety information about Avandia from the public. The FDA is currently weighing its regulatory options.

Read more about FDA Avandia restrictions in an article featured by The New York Times. 

If you or a loved one may have experienced adverse side effects or injuries while taking Avandia or for more information about potential avandia lawsuits, contact Avandia lawyer Adrian Broome or Liza Ward by email or by calling +1 800.768.4026.